+1 (424) 212-4087

Secondary Infertility in Torrance: A Complete Guide to Why Getting Pregnant Again Can Be Harder, and What to Do Next

By the Incinta Editorial Team · Medically reviewed by the Incinta Review Team

The first time may have been quick. Perhaps you stopped using contraception and were pregnant within a few months, or perhaps it took a little planning but no medical help. Now, a year or more into trying for a second child, nothing is happening — and the surprise is often harder to process than the waiting itself. People frequently tell us some version of the same sentence: “But we already proved we could do this.” That assumption is completely understandable, and it is also the single most common reason secondary infertility goes unevaluated for longer than it should.

Fertility is not a fixed trait that, once demonstrated, stays with you. It is a time-dependent outcome of several systems — ovaries, tubes, uterus, sperm, hormones, and general health — any of which can change between one pregnancy and the next. This guide explains what secondary infertility means, why a previous pregnancy does not guarantee a future one, the causes that are specific to the interval between children, when to seek help, what a workup should include, and how treatment decisions are actually made. It complements our complete guide to fertility testing in Torrance, which covers the diagnostic checklist in depth, and our IVF in Torrance overview, which covers treatment itself.

A working definition.

The World Health Organization states: “Infertility can be primary or secondary. Primary infertility is when a pregnancy has never been achieved by a person, and secondary infertility is when at least one prior pregnancy has been achieved.” MedlinePlus puts it more simply: “Secondary infertility refers to couples who have been able to get pregnant at least once, but now are unable to do so.” Infertility itself is defined as the failure to achieve a pregnancy after 12 months or more of regular unprotected intercourse, shortened to six months when the woman is older than 35.

Two framing points matter from the outset. First, infertility is common: the WHO estimates that approximately one in every six people of reproductive age worldwide experience infertility in their lifetime. Second, secondary infertility is a description of your history, not a diagnosis and not a verdict on your chances. It tells a clinician where to start looking; it does not tell them what they will find.

1. What Counts as Secondary Infertility?

The definition hinges on the phrase at least one prior pregnancy — not on a prior live birth. A pregnancy that ended in miscarriage, ectopic pregnancy, stillbirth, or termination still counts as a pregnancy achieved. This matters because people who have never brought a baby home sometimes assume they belong in the primary-infertility category, or assume their losses are irrelevant to the current problem. Neither is correct. Your full pregnancy history is clinically relevant information.

NICHD adds an important nuance: the term infertility is also used for people who can become pregnant but cannot carry a pregnancy to term because of miscarriage, recurrent pregnancy loss, or stillbirth. At the same time, NICHD notes that recurrent pregnancy loss is considered distinct from infertility, because the causes often differ. In practice this means that if your difficulty is repeated loss rather than difficulty conceiving, the evaluation follows a different path — covered in our Recurrent Pregnancy Loss in Torrance guide. Where the two overlap, both paths may be needed.

The time threshold is the same as for primary infertility: NICHD defines infertility as one year of regular, unprotected intercourse without pregnancy, or six months if the woman is older than 35. MedlinePlus gives the same practical rule — one year of trying for women under 30, six months for women over 35 — before testing is recommended. A prior pregnancy does not extend or shorten that clock on its own, although specific risk factors often mean you should not wait at all, as section 11 explains.

One more distinction is worth making. Subfertility is sometimes used for a situation in which pregnancy is still likely without treatment but takes longer than usual; NICHD notes that the terms are related but not identical. Plenty of people in this category conceive on their own. A label is a starting point for a conversation, not a prediction.

2. Why It Catches Families Off Guard

Secondary infertility has a particular emotional signature. The first pregnancy is often treated as evidence of a working system, so when the second does not arrive, the reaction is confusion before it is worry. There is also a social dimension: friends and family may respond with “at least you have one child,” which is usually meant kindly but can leave people feeling that their disappointment is not legitimate. MedlinePlus acknowledges directly that undergoing evaluation and treatment for infertility is stressful for most couples and that emotional stressors may induce depression, anger, anxiety, and strain between partners. Section 14 returns to this.

Clinically, the surprise comes from a hidden variable: time. A first child at 29 and a second attempt at 38 are not the same biological situation, even if nothing else changed. Added to that are events that can only happen after a pregnancy — a cesarean delivery, a postpartum infection, a dilation and curettage after a miscarriage, a new fibroid, a tubal ligation and its reversal, or a partner’s new medication. None of these were present the first time around.

There is also simple probability. MedlinePlus states that healthy couples under age 30 having regular intercourse have about a 20% chance of pregnancy each month. That is a population-level published estimate, not a prediction for any individual, but it explains why even a completely normal couple can take many months. A first pregnancy that happened in cycle two was partly good fortune; expecting the same timing again sets an unrealistic benchmark.

How common is secondary infertility specifically? Published estimates vary substantially depending on the definition used, the population studied, and whether pregnancy losses are counted, so we do not quote a single percentage here. What can be said reliably is that both the WHO and MedlinePlus treat it as a named, recognised category, and that it accounts for a meaningful share of people attending fertility clinics. If you are in this situation, you are not an unusual case.

3. Why a Previous Pregnancy Does Not Guarantee the Next One

It helps to think of fertility as the output of a chain rather than a single organ. For a pregnancy to occur, an egg must be released, picked up by a patent tube, fertilised by competent sperm, and the resulting embryo must implant in a receptive uterine cavity — all under a hormonal environment that supports each step. A previous pregnancy proves the chain worked once. It does not prove that every link still works now.

The changes that matter generally fall into four groups:

  • Egg quantity and quality. The ovarian reserve and the age of the oocytes both change with time, and age remains the strongest single predictor of oocyte quality. See our Age and Fertility in Torrance guide.
  • Anatomy and transport. Tubes and uterine cavity can be altered by infection, surgery, delivery, or new growths such as fibroids and polyps.
  • Sperm and the male partner. A new partner, a new medication, weight change, illness, heat exposure, or age can all change semen parameters.
  • General health and ovulation. Thyroid disease, prolactin abnormalities, PCOS, diabetes, weight change, and some medications can disrupt ovulation even in someone whose cycles used to be textbook regular.

The fourth group is the one most often overlooked because it feels unrelated to reproduction. MedlinePlus lists thyroid disease, diabetes, being overweight or underweight, autoimmune disorders, and certain medicines among the causes of female infertility, and lists obesity, diabetes, infection, some medications, and anabolic steroid use among the male causes. The WHO likewise notes endocrine disorders, lifestyle factors including smoking, excessive alcohol and obesity, and exposure to environmental toxins. These are all things that can develop in the years between children.

The honest frame. A previous pregnancy is useful information — it tells your clinician that the system worked at a particular point in time, and it can effectively rule out some lifelong congenital causes. But it does not rule out anything that developed since. The useful clinical question is not “why did this stop working?” but “what has changed since the last pregnancy?”

4. Cause 1: Age and the Passage of Time Between Children

For most families, the largest single difference between the first pregnancy and the second attempt is simply the number of years between them. Child spacing, career demands, housing, partnership changes, and the demands of raising an existing child all add time. MedlinePlus states that a woman is most fertile in her early 20s, that the chance of pregnancy begins to decrease around age 35 and especially after 40, and that infertility and miscarriage rates increase significantly after 35. Our Age and Fertility in Torrance guide sets out the underlying biology and the published estimates in more detail.

Two separate things change with age, and confusing them leads to poor decisions. The first is quantity: the number of remaining oocytes, which ovarian reserve markers such as AMH and antral follicle count estimate. The second is quality: the proportion of oocytes that are chromosomally normal. Reserve tests say something about the first, not the second. Our AMH and Ovarian Reserve in Torrance guide explains this boundary carefully, including why a low AMH alone does not establish that natural conception is impossible, and why AMH should not be used as a standalone verdict on fertility.

A practical tension follows. Public-health guidance generally encourages adequate spacing between pregnancies for maternal and infant health, while age-related decline creates a reason not to wait indefinitely. There is no universal number that resolves this for every family; it is a conversation to have with a clinician who knows your history, your ovarian reserve, and your priorities. What we would caution against is assuming that because the first pregnancy was easy, waiting carries no cost.

Age also changes the treatment conversation. At older reproductive ages, clinicians are generally less willing to spend many months on low-intensity treatment before moving on, because time itself is a meaningful variable. IUI vs. IVF in Torrance compares those paths, including medication burden and time-to-pregnancy. PGT in Torrance discusses where embryo chromosome testing may and may not be relevant as age-related aneuploidy rises — and is explicit about its limitations. Both are decisions with trade-offs, not upgrades to be added automatically.

Finally, Egg Freezing in Torrance is sometimes raised in this context. It is worth being clear: egg freezing is a planning tool for preserving options before a decline, not a treatment for difficulty conceiving now, and it is not a guarantee of a future baby. Framing it as insurance overstates what the data support.

5. Cause 2: Ovulation and Hormonal Changes Since the Last Pregnancy

Ovulatory dysfunction is one of the more common and more treatable findings in secondary infertility, and it frequently appears in someone whose cycles used to be regular. The pattern to watch for is change: cycles that have become longer, unpredictable, very heavy, or absent, or bleeding that arrives without a clear premenstrual pattern.

  • PCOS. Polycystic ovary syndrome can become clinically apparent later, often in conjunction with weight change or insulin resistance. Our PCOS and Fertility in Torrance guide covers how the diagnosis is made and how ovulation induction is approached.
  • Thyroid disease. Both hypothyroidism and hyperthyroidism can disrupt ovulation and are associated with adverse pregnancy outcomes. MedlinePlus lists thyroid disease and thyroid function testing among the standard causes and tests, and ACOG explains why thyroid testing is part of a basic evaluation. Postpartum thyroiditis is a specific consideration after a recent delivery.
  • Elevated prolactin. Galactorrhea, irregular cycles, or absent ovulation warrant a prolactin check. MedlinePlus notes that a benign pituitary tumour causing high prolactin is a recognised male cause as well.
  • Weight and metabolic change. Both being overweight and being underweight can suppress ovulation; MedlinePlus also lists excessive exercise and eating disorders or poor nutrition. Our Nutrition and Lifestyle for Fertility guide reviews what the evidence does and does not show for weight, diet, and supplements.
  • Medications and chronic illness. Some prescription drugs, chemotherapy, uncontrolled diabetes, and pituitary or hypothalamic disorders can all interfere with ovulation.

Breastfeeding deserves a specific mention because it is unique to this population. Lactation suppresses ovulation through elevated prolactin, and the return of menstruation is variable; some people ovulate before their first postpartum period, so the absence of a period is not reliable contraception, and conversely cycles may remain irregular for a while after weaning. If you are breastfeeding and trying to conceive, that context belongs in the first conversation with your clinician, because the standard twelve-month clock is not straightforward to apply.

The testing principle here is the same as elsewhere: targeted, not indiscriminate. ACOG’s Evaluating Infertility FAQ frames the first visit as a history, examination, and a defined set of tests rather than an open-ended menu. TSH is a standard part of the basic evaluation; prolactin, androgens, and glucose/insulin testing are directed by findings. Our fertility testing hub details which hormone tests are cycle-day dependent and why that affects scheduling.

6. Cause 3: Tubal Damage After Infection, Delivery, or Surgery

This is the category most specific to secondary infertility, because the relevant exposures often happen during or after a pregnancy. The WHO explicitly lists tubal disorders caused by untreated sexually transmitted infections and by complications of unsafe abortion, postpartum sepsis, or abdominal and pelvic surgery among the causes of female infertility. MedlinePlus similarly lists pelvic infection resulting in scarring or swelling of the fallopian tubes (hydrosalpinx), pelvic inflammatory disease, and scarring from sexually transmitted infection, abdominal surgery, or endometriosis.

Events in an interval history that can affect the tubes include:

  • Pelvic inflammatory disease or an untreated chlamydia or gonorrhoea infection.
  • Postpartum or post-cesarean pelvic infection, including retained products requiring instrumentation.
  • Ruptured appendicitis, bowel surgery, or other abdominal/pelvic operations that leave adhesions.
  • Surgery for an ectopic pregnancy, which may involve removing a tube.
  • Tubal ligation for sterilisation, and attempted reversal. MedlinePlus lists both tubal ligation and failure of tubal ligation reversal as recognised causes.

Tubal patency cannot be assessed with a blood test or a standard ultrasound. Hysterosalpingography, or HSG, is the conventional first-line study: contrast is passed through the cervix under X-ray imaging to outline the uterine cavity and show whether dye spills freely from both tubes. MedlinePlus describes it as a special X-ray using dye to look at the womb and fallopian tubes. It has real limitations — cramping, low-dose radiation, contrast allergy, a small infection risk, and proximal tubal spasm that can make a normal tube appear blocked — all of which are covered in our Tubal Factor Infertility in Torrance guide, along with how a finding changes the decision between surgery, IUI, and IVF.

Why this matters for your workup: an HSG is often the single highest-yield test in secondary infertility when there is any history of pelvic infection, postpartum complication, or abdominal surgery. If your prior delivery involved a significant complication, bring the operative report or discharge summary to the first appointment — the details change which tests are worth ordering.

7. Cause 4: Uterine Cavity Changes, Scarring, and Cesarean Scars

The uterine cavity can change between pregnancies too. MedlinePlus lists growths such as fibroids or polyps in the uterus and cervix among the causes of female infertility, and WHO lists uterine disorders including fibroids, congenital anomalies such as a septate uterus, and inflammatory conditions such as endometriosis.

  • Fibroids and polyps. A fibroid that is new, has grown, or now distorts the cavity can affect implantation and miscarriage risk. Our Uterine Fibroids and Fertility in Torrance guide explains which types justify removal and which do not — an important distinction, because removing a fibroid that does not distort the cavity has not been shown to improve fertility outcomes.
  • Intrauterine adhesions. Scar tissue inside the cavity can develop after instrumentation, particularly curettage following a miscarriage, retained placental tissue, or postpartum haemorrhage. This is one reason a detailed obstetric history matters more in secondary than in primary infertility.
  • Adenomyosis and cavity shape. These may be suspected on imaging and sometimes require a different imaging approach to characterise.
  • Cesarean scar. Some observational studies have reported an association between cesarean delivery and later difficulty conceiving, but the evidence is not definitive and confounding is substantial — the reasons a cesarean was needed, maternal age at delivery, and subsequent pregnancy intentions all influence the numbers. It is a reasonable topic to raise, but it should not be presented as settled causation.

A standard transvaginal ultrasound is the starting point but can miss small intracavitary polyps, submucosal fibroids, a septum, or adhesions. Saline infusion sonohysterography separates the endometrial surfaces with fluid during ultrasound; hysteroscopy allows direct visualisation and, in many cases, immediate treatment. The trade-off is invasiveness versus certainty — ultrasound is painless but least sensitive, while hysteroscopy is definitive but a procedure with anaesthesia considerations. Section 12 and our fertility testing guide set out when each is typically ordered.

If your difficulty is repeated early loss rather than difficulty conceiving, the uterine evaluation overlaps with the recurrent pregnancy loss workup, and the two should be coordinated rather than run as separate projects.

8. Cause 5: Endometriosis That Develops or Progresses

Endometriosis is a plausible explanation for secondary infertility precisely because it can be mild or silent during a first pregnancy and more symptomatic years later. WHO lists it among uterine and inflammatory disorders associated with female infertility, and MedlinePlus lists scarring from endometriosis as a cause of infertility.

The management trade-offs are unusually important here, and our Endometriosis and Fertility in Torrance guide covers them in detail. Two are worth flagging. First, hormonal suppression can relieve pain but does not improve the chance of spontaneous conception, because it also suppresses ovulation — it is not a fertility treatment. Second, ovarian surgery for endometriomas can reduce ovarian reserve, so the decision to operate must be weighed against the reserve you already have; our AMH guide explains how that is measured and where the measurement is imprecise. A diagnosis that was irrelevant ten years ago may now change the plan.

Suspicion usually comes from the history — progressive dysmenorrhoea, pain with intercourse, infertility with otherwise normal basic testing — rather than from a blood test. Imaging can identify endometriomas and deep disease, but superficial implants are frequently invisible on ultrasound; ASRM Practice Committee documents discuss the role and limits of surgical diagnosis. This is one of the situations where a specialist’s judgement is genuinely more informative than a checklist.

9. Cause 6: Male Factor Changes Over Time

It is a persistent misconception that because a couple has one child together, the male partner’s fertility is settled. Semen parameters vary with health, medication, weight, heat exposure, illness, and age — and a semen analysis from years ago describes a different moment. MedlinePlus states that infertility may be due to conditions in the woman, the man, or both, and lists obesity, older age, smoking, heavy alcohol or drug use, diabetes, infection, prolonged heat exposure, scarring from surgery or sexually transmitted infections, chemotherapy and radiation, and specific medicines (including cimetidine, spironolactone, and nitrofurantoin) among male causes. The WHO adds varicoceles, hormonal disorders, obstruction, and anabolic steroid use, which can cause abnormal semen parameters.

A semen analysis should be one of the first tests ordered for both primary and secondary infertility. It is non-invasive, relatively inexpensive, and frequently changes the plan. MedlinePlus recommends two to three days without ejaculation before collection (and not longer than five), delivery of the sample to the laboratory within about 30 minutes while kept near body temperature, and analysis within two hours. Reference ranges vary between laboratories and between editions of the WHO laboratory manual; an abnormal result does not by itself mean a man cannot father a child, and a single abnormal sample is usually repeated.

Where a new or progressive male factor is confirmed, our Male Infertility and ICSI in Torrance guide explains the targeted hormonal, urological, and genetic testing that follows, and when ICSI becomes part of an IVF plan. Modifiable factors — smoking, alcohol, anabolic steroids, heat, weight — are covered in our Nutrition and Lifestyle for Fertility guide. One specific point deserves emphasis: exogenous testosterone, sometimes prescribed for low energy or low libido, can suppress sperm production and should never be started without discussing fertility goals with a clinician.

10. Cause 7: A New Partner, New Genetics, and New Medical History

Some interval changes are about the couple rather than either individual. A new partner means a new reproductive and genetic combination, a different semen profile, and possibly a prior vasectomy or known fertility problem. It also means that carrier screening should be revisited: ACOG explains who should be offered screening and how to interpret results, and a negative screen reduces but does not eliminate residual risk. If both partners carry the same recessive condition, that does not mean pregnancy is impossible — it opens a conversation about genetic counselling and, in selected cases, PGT in Torrance.

Other interval events that belong in the history include cancer treatment with chemotherapy or pelvic radiation; new autoimmune or clotting disorders (MedlinePlus lists antiphospholipid syndrome and clotting disorders among female causes); pelvic surgery; a transfusion; significant weight change; and new long-term medications. Contraception history matters too: MedlinePlus lists tubal ligation and failure of reversal, as well as vasectomy and failed vasectomy reversal. Some contraceptive methods are associated with a delay in the return of normal cycles after discontinuation, which is worth discussing if cycles have not resumed.

A caution about a topic that generates a great deal of online noise. Immune panels, natural-killer-cell testing, and empiric immunologic treatments are sometimes marketed to people with unexplained infertility or repeated loss. ASRM Practice Committee documents and ACOG’s Treating Infertility FAQ emphasise that a test should be ordered only when its result will change management, and the proposed immunologic treatments have not demonstrated benefit in unselected patients while carrying cost and risk. Our RPL guide sets out the evidence and the genuine grey areas in detail. A thorough workup does not mean an unlimited one.

11. When to Seek Help After a Previous Pregnancy

Use the same age-based rule as for primary infertility:

  • Under 35: seek an evaluation after 12 months of regular, unprotected intercourse without pregnancy. This matches the WHO and NICHD definitions.
  • 35 to 39: seek an evaluation after 6 months. NICHD and MedlinePlus both shorten the interval to six months over 35.
  • 40 and older: do not wait for a full six months. ASRM practice guidance emphasises prompt assessment in this group; our Age and Fertility in Torrance guide explains the biology behind the shorter timeline.

There are also situations in which waiting is not appropriate at any age, and several are particularly relevant after a previous pregnancy:

  • Absent, very irregular, or newly changed menstrual cycles.
  • A known or suspected tubal problem, a history of pelvic inflammatory disease, postpartum pelvic infection, or ectopic pregnancy.
  • A pregnancy or delivery followed by instrumentation of the uterine cavity, or a postpartum complication.
  • Two or more pregnancy losses — a distinct evaluation, covered in our RPL guide.
  • Diagnosed moderate-to-severe endometriosis, known fibroids distorting the cavity, or known male-factor issues.
  • Prior cancer treatment with chemotherapy or pelvic radiation, or a partner who has had a vasectomy.
  • A first pregnancy that itself took a long time or required fertility treatment — the underlying factor may still be present.

One nuance specific to this article: if cycles have not returned after breastfeeding, after stopping contraception, or after a postpartum complication, a twelve-month clock is not straightforward to apply. Rather than counting months, book a conversation. And if you have a specific concern, an earlier evaluation is reasonable regardless of the calendar — the thresholds are there to prompt investigation, not to make you wait.

12. The Secondary Infertility Workup: What Is Different

The core domains of the evaluation are the same as for primary infertility: ovarian reserve, ovulation, tubal patency, uterine cavity, semen analysis, and targeted hormonal and general-health screening. Our Fertility Testing in Torrance guide is the detailed checklist hub, including cycle-day timing, what each test can and cannot tell you, and which add-ons are not routine. What differs here is the weight placed on interval history and on both partners being tested in parallel.

Start with the interval history

A clinician will want details of every pregnancy and its outcome; mode of delivery and any complications; postpartum infection, haemorrhage, transfusion, or curettage; pelvic or abdominal surgery; new infections; contraception and sterilisation; breastfeeding; menstrual pattern since the last pregnancy; weight change; new diagnoses and all current medications and supplements for both partners. Bring operative reports, discharge summaries, and any prior test results. This history is often what determines whether an HSG, a cavity study, or a targeted endocrine panel is the highest-yield next step.

Both partners, at the same time

MedlinePlus states that infertility testing involves a medical history and physical exam for both partners, and ASRM patient resources describe the parallel evaluation as standard. Deferring the semen analysis while one partner completes months of testing wastes the most useful early information. This is as true the second time as the first — arguably more so, because the assumption of a previously proven male factor can delay it further.

The core tests

  • Ovarian reserve: AMH, antral follicle count, and often cycle-day 2–4 FSH with estradiol. Interpreted as quantity, not quality — AMH guide.
  • Ovulation: mid-luteal progesterone, urinary LH kits, or ultrasound monitoring where cycles are irregular.
  • Tubal patency: HSG, with the limits described above; MedlinePlus and Tubal Factor guide.
  • Uterine cavity: transvaginal ultrasound, then saline infusion sonohysterography or hysteroscopy when indicated — particularly with a history of uterine instrumentation or abnormal bleeding.
  • Semen analysis: early, repeated if abnormal; MedlinePlus.
  • Targeted bloodwork: TSH routinely; prolactin, androgens, and glucose/insulin testing directed by history and examination; ACOG.
  • Preconception and safety screening: infectious disease and immunity screening before any ART cycle, blood type and Rh, and carrier screening offered to both partners. Preconception nutrition belongs in the same conversation; our nutrition guide reviews the evidence, including where it is weak.

What a good workup does not include

Routine immune panels, thrombophilia screening without a relevant history, endometrial receptivity arrays for all patients, sperm DNA fragmentation as a first-line test, routine diagnostic laparoscopy, post-coital testing, and routine endometrial biopsy dating are not part of a standard first-line evaluation. ASRM Practice Committee documents and ACOG both stress that a test should be ordered only when its result will change a decision. This is not an argument against specialised testing in the right context; it is an argument for sequence.

Results commonly fall into four patterns: a clear treatable cause; a finding that changes the plan without explaining the infertility (for example, reduced ovarian reserve); borderline or discordant results that need a carefully timed repeat; and unexplained infertility, which NICHD and ASRM patient resources describe as a recognised outcome of a normal evaluation. Unexplained is a statement about the limits of current testing, not a reason to keep ordering more of it indefinitely.

13. Treatment Pathways and Their Trade-Offs

Treatment should follow from findings, not from a ladder that everyone climbs in the same order. A useful results consultation ends with a written plan naming the findings, the reasoning, the recommended next step, and the criteria for changing course. Broadly, the mapping looks like this:

  • Normal workup, younger patient, short duration: expectant management with cycle timing may be reasonable, with a defined review point. MedlinePlus notes that as many as one in five couples diagnosed with infertility eventually become pregnant without treatment — a population-level published figure, not an individual prediction — and advises intercourse at least every two days before and during ovulation, since sperm can survive at least two days while an egg is fertilisable for only about 12 to 24 hours after release.
  • Ovulatory dysfunction: ovulation induction with timed intercourse or IUI, addressing PCOS, thyroid, weight, and metabolic factors in parallel — PCOS guide.
  • Mild male factor or unexplained infertility: often a limited, agreed number of IUI cycles before reassessment — IUI vs. IVF in Torrance.
  • Cavity lesion or distorting fibroid: surgical correction before transfer or insemination, with a defined waiting period — fibroids guide.
  • Bilateral tubal blockage or severe male factor: IVF, with ICSI for the latter — tubal guide, ICSI guide.
  • Reduced ovarian reserve or age-related time pressure: an earlier move to IVF, with an honest discussion of expected egg yield.
  • Repeated pregnancy loss: a distinct evaluation path — RPL guide.

Each option has a boundary worth stating plainly. Ovulation induction raises the chance of multiple pregnancy and requires monitoring. IUI is less invasive and less costly than IVF but has a lower per-cycle chance of pregnancy, so spending many cycles on it can cost time that matters more at older ages. IVF bypasses the tubes and allows embryo selection but involves stimulation, a procedure, and substantially greater cost and burden — our step-by-step IVF journey guide walks through it, and the IVF in Torrance overview explains how the pieces fit together. PGT has specific indications and does not improve outcomes for everyone. Donor eggs may be discussed for some patients, but that is a significant medical, genetic, and personal decision with its own counselling needs — not a routine escalation. ACOG’s Treating Infertility FAQ and NICHD’s treatment overview provide neutral patient-facing summaries of the main options.

Cost and coverage deserve a direct conversation during this consultation rather than after it. Diagnostic testing, medications, procedures, and ART cycles are frequently billed and covered differently, and coverage varies by plan, employer, and state. ACOG explicitly notes that infertility testing may not be covered by insurance. Ask for a written estimate that itemises each component, and confirm pre-authorisation requirements in writing before scheduling. Any figures you see quoted online — including in general patient resources — are typical ranges, not a clinic quote, an estimate, an offer, or a prediction, and should not be used for budgeting without a written assessment from your own care team.

Practical Next Steps

  1. Write down what has changed since your last pregnancy: dates, deliveries, complications, surgeries, infections, medications, cycle changes, and breastfeeding.
  2. Gather operative reports, discharge summaries, and prior test results for both partners before the first visit.
  3. Plan for both partners to attend. Parallel testing shortens the time to a plan and avoids re-testing old assumptions.
  4. Ask which tests are cycle-day dependent, and get a written schedule rather than ordering piecemeal.
  5. Ask for the rationale behind each test: what decision will this result change?
  6. Request a written summary of results and a plan with a defined review point, including what remains unexplained.
  7. Clarify insurance coverage and get an itemised written estimate before any procedure.

If you would like to discuss an evaluation, our team can be reached through the fertility services page. A previous pregnancy tells us the system once worked; a good evaluation tells us what is true now, which is the information you actually need to make a decision.

14. The Emotional Side — and Keeping It in Proportion

Secondary infertility is frequently minimised, including by the people experiencing it. There can be guilt about wanting another child when one is already healthy, reluctance to talk about it in front of that child, isolation from friends who are moving on to a different stage of life, and strain between partners who are grieving on different schedules. MedlinePlus acknowledges that infertility evaluation and treatment is stressful for most couples and that emotional stressors may induce depression, anger, anxiety, and marital discord; it also suggests asking a provider to recommend local support groups. The WHO likewise describes significant negative social impacts including emotional stress, depression, anxiety, and low self-esteem.

Two points help keep this in proportion. First, the distress is real and deserves support in its own right — it does not need to be justified by a diagnosis, and it is not made smaller by an existing child. Second, stress is not a satisfactory explanation for infertility. Mind-body and counselling support can meaningfully reduce anxiety and improve coping, but the evidence that stress reduction increases pregnancy rates is weak; our nutrition and lifestyle guide covers this distinction. Nobody should be told that their difficulty conceiving is because they are too stressed, or that relaxing will fix a blocked tube or a low sperm count.

Practical supports that many people find useful include agreeing with your partner in advance on how long you will try each step before reassessing, setting a boundary on how much online searching is helpful, choosing one person outside the couple to talk to, and asking the clinic for a single point of contact for results. A written plan with a review date is not just good medicine — it is also one of the more effective ways to reduce the uncertainty that makes this process hard.

On probabilities: published figures for infertility prevalence, miscarriage, spontaneous conception, treatment response, and ART outcomes are population-level estimates from sources such as the WHO, NICHD, MedlinePlus, ACOG, and ASRM. They describe typical ranges observed across large groups, not a quote, an estimate, an offer, or a prediction for any individual, and they are not clinic-specific success rates. Your own prognosis depends on your evaluation and should be discussed against a written assessment from your care team.

Frequently Asked Questions

What is the difference between primary and secondary infertility?

Primary infertility means a pregnancy has never been achieved; secondary infertility means at least one prior pregnancy has been achieved but a new pregnancy is not occurring. WHO and MedlinePlus both use this distinction. Importantly, a prior pregnancy includes one that ended in miscarriage, ectopic pregnancy, stillbirth, or termination — it does not require a live birth. The evaluation threshold is the same for both: 12 months of regular unprotected intercourse, shortened to six months when the woman is over 35.

If I got pregnant easily before, do I still need a full workup?

Usually yes, though the emphasis may differ. A previous pregnancy rules out some lifelong congenital causes but says nothing about anything that developed since: age-related changes in ovarian reserve, tubal damage after infection or surgery, new fibroids or polyps, thyroid or ovulatory problems, and changes in semen parameters. The standard domains still apply for both partners — ovarian reserve, ovulation, tubal patency, uterine cavity, and semen analysis — with extra attention to your interval and obstetric history. ACOG’s Evaluating Infertility FAQ describes the basic evaluation, and our Fertility Testing in Torrance guide explains each component.

Does a cesarean delivery cause secondary infertility?

The evidence is not definitive. Some observational studies have reported an association between cesarean delivery and later difficulty conceiving, but confounding is substantial: the medical reasons the cesarean was needed, maternal age, postpartum infection, and subsequent pregnancy intentions all affect the numbers. WHO lists postpartum sepsis and abdominal or pelvic surgery as causes of tubal disorders, so a postoperative infection or adhesions are plausible mechanisms worth evaluating — but cesarean delivery itself should not be assumed to be the cause. An HSG and a review of the operative record are more informative than a general assumption.

How long should we try before seeing a specialist for a second child?

Use the same 12 / 6 / 3 rule: 12 months under 35, six months from 35 to 39, and prompt assessment at 40 or older. Do not wait at all if cycles are absent or newly irregular, if there is a history of pelvic infection, ectopic pregnancy, postpartum complication, two or more losses, known endometriosis or male factor, prior cancer treatment, or if the first pregnancy itself required fertility treatment. If you are breastfeeding or your cycles have not returned, book a conversation rather than counting months. NICHD and MedlinePlus both state the age-based thresholds.

Can breastfeeding or irregular periods delay pregnancy again?

Yes. Lactation suppresses ovulation through elevated prolactin, and the return of menstruation and ovulation varies widely between individuals. Some people ovulate before their first postpartum period, so absence of a period is not reliable contraception; conversely, cycles may remain irregular for a while after weaning. If cycles have not returned after stopping contraception or after a postpartum complication, that is worth evaluating rather than waiting. Thyroid abnormalities, including postpartum thyroiditis, and elevated prolactin are also relevant and are part of a targeted hormone evaluation.

Will insurance cover testing and treatment for secondary infertility?

It depends on your plan, employer, and state, and diagnostic testing is often covered differently from treatment. ACOG’s Evaluating Infertility FAQ specifically notes that infertility testing is not always covered by insurance. Ask your insurer whether a referral or pre-authorisation is needed, and ask the clinic for an itemised written estimate before scheduling. Any cost figures quoted in general patient resources are typical ranges, not a clinic quote, an estimate, or an offer, and should be confirmed in writing against your own assessment.

Medical disclaimer

This article is for general education only and is not medical advice, a diagnosis, or a treatment recommendation. It does not replace an individual evaluation by a qualified clinician. Test selection, reference ranges, and interpretation differ between laboratories and should always be reviewed with your own care team. Statistics and ranges cited here are population-level figures from public health and professional sources (WHO, NICHD, MedlinePlus, ACOG, ASRM and their patient resources); they are not clinic-specific success rates, not a quote, not an estimate, not an offer, and not a prediction of your outcome. Any costs must be confirmed in a written assessment. If you have a specific medical question, please speak with a licensed healthcare professional.

By the Incinta Editorial Team · Medically reviewed by the Incinta Review Team

Incinta Fertility Center — Fertility Clinic Torrance & South Bay, California

Call us: +1 (424) 212-4087